Raybow Pharmaceutical

Raybow Pharmaceutical has demonstrated how environmental disclosure can drive measurable gains in operational efficiency. In 2025, the company achieved a CDP A score in water security through implementing advanced green chemistry capabilities.

Driven by rising customer expectations on environmental performance, the company has embedded climate, water and emissions management into its core operations—integrating sustainability directly into day-to-day decision-making and execution.

Translating disclosure into action

• Raybow has aligned site-level implementation with its parent company’s ESG governance framework and the CDP disclosure framework, enabling coordinated action across Environment, Health, and Safety practices, production, procurement and engineering teams.

• A dedicated CDP working group standardizes data boundaries, improves data consistency and strengthens internal accountability.

• The company uses CDP disclosure to identify gaps in energy use, waste and resource efficiency—translating insights into targeted improvement projects.

Driving measurable impact

• Through process innovation, including continuous flow chemistry, the company has reduced energy consumption, processing time and waste generation, while improving product yield.

• It has applied green chemistry and biotechnology solutions, supported by a microbial strain library of 900+ strains across 20+ process pathways, enabling scalable low-impact production.

• Equipment upgrades and enhanced metering systems have improved resource efficiency and data accuracy, supporting ongoing optimization.

Raybow Pharmaceutical’s experience highlights how structured environmental disclosure can strengthen operational discipline, helping translate environmental data into better process design, resource management and production performance.